LIDOCAINE HCL 3%

LIDOCAINE HCL 3% was reported 459 times

LIDOCAINE HCL 3% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARBOXYHAEMOGLOBINAEMIA 1 0.0769
1 BENIGN DUODENAL NEOPLASM 1 0.0769
2 RADICAL NECK DISSECTION 1 0.0625
3 INJECTION SITE JOINT REDNESS 1 0.0588
4 TRIGEMINAL PALSY 2 0.0435
5 INFILTRATION ANAESTHESIA 1 0.0312
6 GASTRIC ULCER SURGERY 1 0.0250
7 PELVIC FLOOR DYSSYNERGIA 1 0.0238
8 BLOOD METHAEMOGLOBIN PRESENT 2 0.0180
9 INJECTION SITE JOINT SWELLING 1 0.0179
10 OROPHARYNGEAL DISCOLOURATION 1 0.0172
11 BRONCHIAL INJURY 1 0.0172
12 FASCIAL RUPTURE 1 0.0169
13 BRONCHOALVEOLAR LAVAGE 1 0.0164
14 MENINGEAL NEOPLASM 1 0.0149
15 DURAL TEAR 1 0.0128
16 BURKHOLDERIA INFECTION 1 0.0120
17 PLATELET AGGREGATION INHIBITION 1 0.0109
18 CENTRAL NERVOUS SYSTEM MASS 1 0.0105
19 CARDIAC INDEX DECREASED 1 0.0097
20 MONONEUROPATHY 2 0.0096
21 MENINGITIS CHEMICAL 2 0.0091
22 TOXIC ANTERIOR SEGMENT SYNDROME 8 0.0073
23 CRYPTOCOCCAL FUNGAEMIA 1 0.0070
24 FEAR-RELATED AVOIDANCE OF ACTIVITIES 1 0.0066
25 ADAMS-STOKES SYNDROME 1 0.0065
26 HERPES ZOSTER INFECTION NEUROLOGICAL 1 0.0063
27 SERUM SEROTONIN DECREASED 1 0.0063
28 PNEUMOCEPHALUS 2 0.0060
29 TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0055
30 ENDOTRACHEAL INTUBATION COMPLICATION 3 0.0051
31 CARDIAC PROCEDURE COMPLICATION 3 0.0049
32 GRAM STAIN POSITIVE 1 0.0049
33 GENITAL DISORDER MALE 1 0.0047
34 PARALYSIS FLACCID 1 0.0046
35 NEUROMUSCULAR BLOCKADE 1 0.0045
36 ANAESTHETIC COMPLICATION 12 0.0045
37 FAMILIAL PERIODIC PARALYSIS 1 0.0044
38 ANTERIOR CHAMBER DISORDER 1 0.0043
39 TYPE IIA HYPERLIPIDAEMIA 1 0.0043
40 MENINGITIS FUNGAL 1 0.0043
41 MYCOBACTERIUM CHELONAE INFECTION 3 0.0041
42 DENTURE WEARER 1 0.0039
43 AIRWAY COMPLICATION OF ANAESTHESIA 1 0.0038
44 SYRINGOMYELIA 1 0.0036
45 WRONG PRODUCT STORED 1 0.0035
46 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
47 MONARTHRITIS 1 0.0033
48 HAEMORRHOIDS THROMBOSED 1 0.0033
49 INTESTINAL FUNCTIONAL DISORDER 2 0.0032
50 URTICARIA GENERALISED 2 0.0031
51 INTRACRANIAL HYPOTENSION 2 0.0031
52 UNWANTED AWARENESS DURING ANAESTHESIA 1 0.0030
53 SOFT TISSUE INFLAMMATION 1 0.0030
54 JOINT ABSCESS 1 0.0029
55 SMALL CELL LUNG CANCER METASTATIC 1 0.0028
56 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 3 0.0028
57 SERUM SEROTONIN INCREASED 1 0.0028
58 ANTIDEPRESSANT DRUG LEVEL INCREASED 1 0.0028
59 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 1 0.0028
60 ESCHAR 2 0.0027
61 SOFT TISSUE HAEMORRHAGE 1 0.0027
62 CAUDA EQUINA SYNDROME 2 0.0026
63 ADMINISTRATION SITE REACTION 1 0.0026
64 PRODUCT CONTAMINATION MICROBIAL 3 0.0025
65 SPUTUM CULTURE POSITIVE 2 0.0025
66 SPINAL DECOMPRESSION 1 0.0024
67 CORONARY ARTERY ATHEROSCLEROSIS 1 0.0024
68 CORNEAL OEDEMA 5 0.0022
69 ANAESTHETIC COMPLICATION NEUROLOGICAL 2 0.0022
70 IMPLANT SITE REACTION 1 0.0022
71 RETINAL SCAR 1 0.0022
72 CHONDROLYSIS 1 0.0021
73 TUMOUR INVASION 1 0.0021
74 BRAIN STEM STROKE 1 0.0020
75 CATARACT OPERATION COMPLICATION 1 0.0020
76 TRACHEAL DISORDER 1 0.0019
77 INTERVERTEBRAL DISC DISPLACEMENT 1 0.0019
78 ACUTE INTERSTITIAL PNEUMONITIS 1 0.0019
79 ENZYME ABNORMALITY 1 0.0019
80 PRODUCT CLOSURE ISSUE 1 0.0018
81 METHAEMOGLOBINAEMIA 4 0.0017
82 SPINAL EPIDURAL HAEMATOMA 1 0.0017
83 THALAMIC INFARCTION 1 0.0017
84 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 2 0.0016
85 BLADDER IRRITATION 1 0.0016
86 ANOXIC ENCEPHALOPATHY 1 0.0016
87 IATROGENIC INJURY 2 0.0016
88 DEVICE BATTERY ISSUE 1 0.0015
89 GALLBLADDER PAIN 1 0.0015
90 INFUSION SITE URTICARIA 1 0.0015
91 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 1 0.0015
92 ARTHRITIS BACTERIAL 6 0.0015
93 SCROTAL OEDEMA 1 0.0014
94 INFECTION IN AN IMMUNOCOMPROMISED HOST 1 0.0014
95 SMALL FIBRE NEUROPATHY 1 0.0014
96 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
97 BRAIN STEM SYNDROME 1 0.0013
98 CHOLANGITIS ACUTE 1 0.0013
99 REFLUX OESOPHAGITIS 1 0.0013
100 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
101 LABORATORY TEST INTERFERENCE 1 0.0013
102 OPHTHALMOPLEGIA 2 0.0013
103 ELECTROMECHANICAL DISSOCIATION 1 0.0013
104 CHEMICAL INJURY 1 0.0012
105 ANAL ULCER 1 0.0012
106 PERIORBITAL HAEMATOMA 1 0.0012
107 AMAUROSIS 1 0.0012
108 COLONIC ABSCESS 1 0.0012
109 ADENOMA BENIGN 1 0.0012
110 INJECTION SITE OEDEMA 2 0.0012
111 RECALLED PRODUCT 2 0.0012
112 SPINAL CORD INJURY 2 0.0011
113 MUSCLE SWELLING 1 0.0011
114 EXTENSOR PLANTAR RESPONSE 1 0.0011
115 PRODUCT APPEARANCE CONFUSION 1 0.0011
116 HAEMOCHROMATOSIS 1 0.0011
117 DELAYED RECOVERY FROM ANAESTHESIA 1 0.0011
118 CEREBELLAR ATAXIA 1 0.0010
119 MATERNAL EXPOSURE DURING DELIVERY 1 0.0010
120 HEMIANOPIA 1 0.0010
121 CREPITATIONS 3 0.0010
122 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
123 BRAIN STEM INFARCTION 1 0.0010
124 CONJUNCTIVAL OEDEMA 1 0.0010
125 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
126 NEUROMYOPATHY 1 0.0009
127 ABSCESS LIMB 4 0.0009
128 INFUSION SITE MASS 1 0.0009
129 OCULAR TOXICITY 1 0.0009
130 NEPHROSCLEROSIS 1 0.0009
131 OPEN WOUND 1 0.0009
132 CATHETER RELATED COMPLICATION 1 0.0009
133 VITH NERVE PARALYSIS 1 0.0009
134 PUPILS UNEQUAL 1 0.0009
135 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
136 SICK SINUS SYNDROME 1 0.0009
137 ADMINISTRATION SITE PAIN 1 0.0009
138 PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0009
139 AORTIC THROMBOSIS 1 0.0009
140 RECTAL ULCER 1 0.0009
141 HYPERTENSIVE EMERGENCY 1 0.0008
142 PRETERM PREMATURE RUPTURE OF MEMBRANES 1 0.0008
143 CHRONIC RESPIRATORY FAILURE 1 0.0008
144 PANCREATIC NEOPLASM 1 0.0008
145 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
146 BREECH PRESENTATION 1 0.0008
147 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
148 LIP DISCOLOURATION 1 0.0008
149 EXCORIATION 2 0.0008
150 BRONCHIAL SECRETION RETENTION 1 0.0008
151 PROCEDURAL COMPLICATION 6 0.0008
152 FEELINGS OF WORTHLESSNESS 1 0.0008
153 INTESTINAL MASS 1 0.0007
154 PELVIC VENOUS THROMBOSIS 1 0.0007
155 FOOT AMPUTATION 1 0.0007
156 NODAL RHYTHM 1 0.0007
157 HYPERTHERMIA MALIGNANT 1 0.0007
158 IMPETIGO 1 0.0007
159 ENDOPHTHALMITIS 4 0.0007
160 ADHESION 1 0.0007
161 HEAT STROKE 1 0.0007
162 INFECTIOUS PLEURAL EFFUSION 1 0.0007
163 MYOGLOBIN BLOOD INCREASED 1 0.0007
164 INJECTION SITE PARAESTHESIA 1 0.0007
165 CRYPTOCOCCOSIS 1 0.0006
166 DENTAL IMPLANTATION 1 0.0006
167 THROMBOSIS IN DEVICE 2 0.0006
168 INJECTION RELATED REACTION 1 0.0006
169 QUADRIPARESIS 1 0.0006
170 DRUG TOXICITY 8 0.0006
171 PRODUCT COUNTERFEIT 1 0.0006
172 VASCULAR PSEUDOANEURYSM 1 0.0006
173 MENINGITIS CRYPTOCOCCAL 1 0.0006
174 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
175 TYPE I HYPERSENSITIVITY 2 0.0006
176 MUSCLE CRAMP 1 0.0006
177 PARAPARESIS 1 0.0006
178 CARDIAC ABLATION 1 0.0006
179 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
180 OPHTHALMIC HERPES ZOSTER 1 0.0006
181 ESSENTIAL HYPERTENSION 1 0.0005
182 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
183 BLOOD BICARBONATE DECREASED 1 0.0005
184 MYELOPATHY 1 0.0005
185 HYPOREFLEXIA 1 0.0005
186 TRAUMATIC LUNG INJURY 1 0.0005
187 ATROPHY 1 0.0005
188 DIPLEGIA 1 0.0005
189 CORONARY ARTERY THROMBOSIS 1 0.0005
190 SINUS TACHYCARDIA 7 0.0005
191 VASCULAR STENT THROMBOSIS 1 0.0005
192 INJECTION SITE NECROSIS 1 0.0005
193 QUADRIPLEGIA 1 0.0005
194 POST PROCEDURAL COMPLICATION 9 0.0005
195 OCULOGYRIC CRISIS 1 0.0005
196 HYPERPHOSPHATAEMIA 1 0.0005
197 EXOPHTHALMOS 1 0.0005
198 NOSOCOMIAL INFECTION 1 0.0005
199 BACTERIAL TEST POSITIVE 1 0.0004
200 PERIARTHRITIS 1 0.0004
201 BRAIN OPERATION 1 0.0004
202 EYELID DISORDER 1 0.0004
203 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
204 ORAL SURGERY 1 0.0004
205 CONTRAST MEDIA REACTION 1 0.0004
206 LONG QT SYNDROME 1 0.0004
207 PRODUCT PACKAGING CONFUSION 1 0.0004
208 BRONCHITIS CHRONIC 1 0.0004
209 DERMAL CYST 1 0.0004
210 DENTAL OPERATION 1 0.0004
211 PENIS DISORDER 1 0.0004
212 INJECTION SITE ABSCESS 1 0.0004
213 TACHYARRHYTHMIA 1 0.0004
214 CATHETER SITE HAEMORRHAGE 1 0.0004
215 RETINAL ARTERY OCCLUSION 1 0.0004
216 ENDODONTIC PROCEDURE 1 0.0004
217 HERNIA REPAIR 1 0.0004
218 PHARMACEUTICAL PRODUCT COMPLAINT 10 0.0004
219 HEPATITIS TOXIC 1 0.0004
220 INJECTION SITE DISCHARGE 2 0.0004
221 GASTRIC PERFORATION 1 0.0004
222 HYPERAESTHESIA 3 0.0004
223 SERUM SICKNESS 1 0.0004
224 LUNG CONSOLIDATION 1 0.0004
225 DIABETIC COMA 1 0.0004
226 ACUTE PULMONARY OEDEMA 2 0.0004
227 HYPERTONIA 2 0.0003
228 PARAPLEGIA 1 0.0003
229 HAEMOTHORAX 1 0.0003
230 EYELID OEDEMA 4 0.0003
231 STRESS CARDIOMYOPATHY 2 0.0003
232 PRODUCT LABEL CONFUSION 2 0.0003
233 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
234 LUMBAR SPINAL STENOSIS 1 0.0003
235 STRIDOR 1 0.0003
236 ENERGY INCREASED 2 0.0003
237 WRONG DRUG ADMINISTERED 3 0.0003
238 INFUSION SITE REACTION 1 0.0003
239 BLOOD CULTURE POSITIVE 1 0.0003
240 REBOUND ACID HYPERSECRETION 1 0.0003
241 INJECTION SITE VESICLES 2 0.0003
242 MUSCLE SPASTICITY 4 0.0003
243 FIBROSIS 1 0.0003
244 INVESTIGATION 1 0.0003
245 RESPIRATORY RATE DECREASED 1 0.0003
246 INFUSION SITE PRURITUS 1 0.0003
247 PORTAL VEIN THROMBOSIS 1 0.0003
248 LIVER ABSCESS 1 0.0003
249 HYPOVENTILATION 1 0.0003
250 INJECTION SITE INFECTION 1 0.0003
251 INFUSION SITE HAEMORRHAGE 1 0.0003
252 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
253 MENINGITIS 2 0.0003
254 EYELID PTOSIS 3 0.0003
255 DRY THROAT 3 0.0003
256 PRODUCT LABEL ISSUE 2 0.0003
257 ECCHYMOSIS 2 0.0003
258 LEFT VENTRICULAR FAILURE 1 0.0003
259 GRANULOMA 1 0.0003
260 EXTRASYSTOLES 2 0.0003
261 LOGORRHOEA 1 0.0003
262 THERMAL BURN 2 0.0003
263 RETINAL HAEMORRHAGE 2 0.0003
264 APPARENT DEATH 1 0.0003
265 DIPLOPIA 7 0.0003
266 NEURODERMATITIS 1 0.0003
267 PARANASAL SINUS DISCOMFORT 1 0.0003
268 DERMATITIS CONTACT 3 0.0003
269 CLAVICLE FRACTURE 1 0.0003
270 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
271 CARDIOPULMONARY FAILURE 1 0.0003
272 TORSADE DE POINTES 2 0.0003
273 RESPIRATORY ACIDOSIS 1 0.0003
274 SKIN ODOUR ABNORMAL 1 0.0003
275 CANDIDIASIS 1 0.0002
276 POST PROCEDURAL INFECTION 2 0.0002
277 VENTRICULAR TACHYCARDIA 4 0.0002
278 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
279 INFUSION SITE ERYTHEMA 2 0.0002
280 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
281 FACIAL PARALYSIS 2 0.0002
282 PSEUDOMONAS INFECTION 2 0.0002
283 TEARFULNESS 1 0.0002
284 METASTATIC NEOPLASM 1 0.0002
285 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
286 LUNG INFILTRATION 2 0.0002
287 ABDOMINAL ABSCESS 1 0.0002
288 RESPIRATORY RATE INCREASED 2 0.0002
289 PAPILLOEDEMA 1 0.0002
290 DRUG EFFECT DELAYED 1 0.0002
291 GRAND MAL CONVULSION 2 0.0002
292 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
293 NEPHROGENIC ANAEMIA 1 0.0002
294 ARTHRITIS INFECTIVE 1 0.0002
295 HEPATIC STEATOSIS 4 0.0002
296 MULTIPLE MYELOMA 1 0.0002
297 PERFORMANCE STATUS DECREASED 1 0.0002
298 STAPHYLOCOCCAL INFECTION 7 0.0002
299 SKIN ABRASION 1 0.0002
300 BRONCHOSPASM 3 0.0002
301 GESTATIONAL DIABETES 1 0.0002
302 CARDIOGENIC SHOCK 3 0.0002
303 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
304 APHAGIA 1 0.0002
305 VULVOVAGINAL PAIN 1 0.0002
306 HUMERUS FRACTURE 1 0.0002
307 ATELECTASIS 2 0.0002
308 GUILLAIN-BARRE SYNDROME 1 0.0002
309 BREATH SOUNDS ABNORMAL 1 0.0002
310 STAPHYLOCOCCAL SEPSIS 1 0.0002
311 HOSPICE CARE 2 0.0002
312 BLADDER DISORDER 2 0.0002
313 ABDOMINAL TENDERNESS 1 0.0002
314 PROTEIN URINE PRESENT 1 0.0002
315 HEPATIC ENZYME ABNORMAL 1 0.0002
316 CORONARY ARTERY STENOSIS 1 0.0002
317 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
318 TOE AMPUTATION 1 0.0002
319 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
320 PHARYNGEAL OEDEMA 3 0.0002
321 FOETAL DEATH 1 0.0002
322 PARTIAL SEIZURES 1 0.0002
323 NYSTAGMUS 1 0.0002
324 PHARYNGOLARYNGEAL PAIN 1 0.0002
325 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
326 FOOD POISONING 1 0.0002
327 ANAL ABSCESS 1 0.0002
328 FAECALOMA 1 0.0002
329 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
330 NECROSIS 1 0.0002
331 PREMATURE LABOUR 1 0.0002
332 GENERALISED ERYTHEMA 1 0.0002
333 EXERCISE TOLERANCE DECREASED 1 0.0002
334 HYPERVENTILATION 1 0.0002
335 SKIN WARM 1 0.0002
336 CAESAREAN SECTION 2 0.0002
337 HYPERTRIGLYCERIDAEMIA 1 0.0002
338 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
339 MUSCLE RIGIDITY 2 0.0002
340 NEURALGIA 4 0.0002
341 DERMATITIS ACNEIFORM 1 0.0002
342 DRUG ABUSER 1 0.0002
343 INJECTION SITE EXTRAVASATION 2 0.0002
344 SCOLIOSIS 1 0.0002
345 CHOLANGITIS 1 0.0002
346 OLIGURIA 1 0.0002
347 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
348 ILEUS 2 0.0002
349 INFUSION SITE EXTRAVASATION 1 0.0002
350 NASAL DRYNESS 1 0.0002
351 SCREAMING 1 0.0002
352 INTRAOCULAR PRESSURE INCREASED 2 0.0002
353 MYDRIASIS 2 0.0002
354 INFUSION SITE PAIN 2 0.0002
355 INJECTION SITE INDURATION 2 0.0002
356 APPLICATION SITE VESICLES 1 0.0002
357 TENDON DISORDER 1 0.0002
358 URINARY RETENTION 5 0.0001
359 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
360 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
361 METASTASES TO LYMPH NODES 1 0.0001
362 WRONG PRODUCT ADMINISTERED 1 0.0001
363 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
364 INFARCTION 1 0.0001
365 APPLICATION SITE RASH 2 0.0001
366 DEFAECATION URGENCY 1 0.0001
367 HALLUCINATION, VISUAL 3 0.0001
368 HYPOXIA 5 0.0001
369 RETCHING 3 0.0001
370 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
371 VISUAL FIELD DEFECT 1 0.0001
372 GASTROENTERITIS 2 0.0001
373 APPLICATION SITE PAIN 3 0.0001
374 SENSITIVE SKIN 1 0.0001
375 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
376 RESPIRATORY DISORDER 4 0.0001
377 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
378 APPLICATION SITE PRURITUS 3 0.0001
379 BRADYCARDIA 7 0.0001
380 HAEMODYNAMIC INSTABILITY 1 0.0001
381 ACIDOSIS 1 0.0001
382 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
383 RENAL FAILURE CHRONIC 1 0.0001
384 ATRIOVENTRICULAR BLOCK 1 0.0001
385 LUNG INFECTION 2 0.0001
386 EJECTION FRACTION DECREASED 2 0.0001
387 APNOEA 1 0.0001
388 SWOLLEN TONGUE 4 0.0001
389 GASTROINTESTINAL INFLAMMATION 1 0.0001
390 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
391 CYANOSIS 2 0.0001
392 MEDICATION ERROR 7 0.0001
393 LOW BIRTH WEIGHT BABY 1 0.0001
394 ABSCESS 2 0.0001
395 MIOSIS 1 0.0001
396 SENSORY LOSS 1 0.0001
397 RHINITIS 1 0.0001
398 MUSCLE DISORDER 1 0.0001
399 BLOOD POTASSIUM INCREASED 2 0.0001
400 DECUBITUS ULCER 1 0.0001
401 CONVULSION 7 0.0001
402 ABNORMAL FAECES 1 0.0001
403 LETHARGY 7 0.0001
404 CARDIAC ARREST 10 0.0001
405 MENSTRUAL DISORDER 1 0.0001
406 EMBOLISM 1 0.0001
407 FACE OEDEMA 2 0.0001
408 INADEQUATE ANALGESIA 1 0.0001
409 CIRCULATORY COLLAPSE 2 0.0001
410 SCAR 2 0.0001
411 CARDIAC OPERATION 1 0.0001
412 ANURIA 1 0.0001
413 SKIN ULCER 3 0.0001
414 BLOOD MAGNESIUM DECREASED 1 0.0001
415 MULTI-ORGAN FAILURE 2 0.0001
416 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
417 APPLICATION SITE ERYTHEMA 3 0.0001
418 NEUROTOXICITY 2 0.0001
419 GROIN PAIN 1 0.0001
420 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
421 GOUT 2 0.0001
422 LOSS OF LIBIDO 1 0.0001
423 ANAL INCONTINENCE 1 0.0001
424 CRYING 4 0.0001
425 END STAGE RENAL DISEASE 2 0.0001
426 EXOSTOSIS 1 0.0001
427 ACCIDENTAL OVERDOSE 4 0.0001
428 RESPIRATORY ARREST 3 0.0001
429 OXYGEN SATURATION DECREASED 6 0.0001
430 PHOTOPHOBIA 2 0.0001
431 LACERATION 1 0.0001
432 DYSARTHRIA 4 0.0001
433 SQUAMOUS CELL CARCINOMA 1 0.0001
434 RECALLED PRODUCT ADMINISTERED 1 0.0001
435 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
436 SEROTONIN SYNDROME 2 0.0001
437 DYSTONIA 2 0.0001
438 AUTOIMMUNE DISORDER 1 0.0001
439 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
440 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
441 THERAPY CHANGE 1 0.0001
442 INABILITY TO AFFORD MEDICATION 1 0.0001
443 PERITONITIS BACTERIAL 1 0.0001
444 MOTOR DYSFUNCTION 1 0.0001
445 THERAPY CESSATION 5 0.0001
446 VENTRICULAR EXTRASYSTOLES 1 0.0001
447 PULMONARY HYPERTENSION 2 0.0001
448 TENDERNESS 1 0.0001
449 WEIGHT FLUCTUATION 1 0.0001
450 AGITATION 7 0.0001
451 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
452 JOINT DISLOCATION 1 0.0001
453 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
454 IMPAIRED WORK ABILITY 2 0.0001
455 DRUG EFFECT DECREASED 5 0.0001
456 OSTEONECROSIS 3 0.0001
457 ASPIRATION 1 0.0001
458 VISUAL ACUITY REDUCED 3 0.0001
459 VENTRICULAR FIBRILLATION 1 0.0001
460 NERVE INJURY 1 0.0001
461 HYPOTENSION 18 0.0001
462 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
463 SINUSITIS 9 0.0001
464 SCAB 1 0.0001
465 MICTURITION URGENCY 1 0.0001
466 MUSCLE TWITCHING 2 0.0001
467 ELECTROLYTE IMBALANCE 1 0.0001
468 ATAXIA 1 0.0001
469 BACTERAEMIA 1 0.0001
470 PRODUCT ADHESION ISSUE 3 0.0001
471 THYROID CANCER 1 0.0001
472 LOCALISED INFECTION 2 0.0001
473 ADRENAL INSUFFICIENCY 1 0.0001
474 FIBROMYALGIA 2 0.0001
475 PRESYNCOPE 2 0.0001
476 NO THERAPEUTIC RESPONSE 1 0.0001
477 ENCEPHALOPATHY 2 0.0001
478 CARDIOMEGALY 1 0.0001
479 HYPERCALCAEMIA 1 0.0001
480 INJECTION SITE DISCOLOURATION 1 0.0001
481 BRAIN OEDEMA 1 0.0001
482 MUSCLE ATROPHY 1 0.0001
483 INJECTION SITE IRRITATION 1 0.0001
484 ROTATOR CUFF SYNDROME 1 0.0001
485 ANOREXIA 1 0.0001
486 ANAPHYLACTIC SHOCK 2 0.0001
487 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
488 UNRESPONSIVE TO STIMULI 2 0.0001
489 HIATUS HERNIA 1 0.0001
490 NODULE 1 0.0001
491 GASTRITIS 2 0.0001
492 TOOTH INFECTION 1 0.0001
493 PULMONARY CONGESTION 1 0.0001
494 EAR INFECTION 2 0.0001
495 QUALITY OF LIFE DECREASED 1 0.0001
496 SINUS CONGESTION 1 0.0001
497 PRODUCT QUALITY ISSUE 10 0.0001
498 PALLOR 2 0.0001
499 PERIPHERAL COLDNESS 1 0.0001
500 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
501 HAEMATOCHEZIA 4 0.0001
502 POLLAKIURIA 3 0.0001
503 COORDINATION ABNORMAL 1 0.0001
504 MASS 1 0.0001
505 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
506 SKIN REACTION 1 0.0001
507 BLINDNESS UNILATERAL 1 0.0001
508 HEPATOCELLULAR INJURY 1 0.0001
509 PARALYSIS 1 0.0001
510 PARAESTHESIA ORAL 1 0.0001
511 HYPOKINESIA 1 0.0001
512 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
513 CARDIOMYOPATHY 1 0.0001
514 URINARY INCONTINENCE 2 0.0001
515 RENAL INJURY 2 0.0001
516 PULMONARY MASS 1 0.0001
517 PULMONARY OEDEMA 3 0.0001
518 THROAT IRRITATION 3 0.0001
519 BLOOD POTASSIUM DECREASED 2 0.0001
520 HYPOAESTHESIA ORAL 1 0.0001
521 APHASIA 2 0.0001
522 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
523 DRUG DISPENSING ERROR 1 0.0001
524 INSURANCE ISSUE 1 0.0001
525 HIP ARTHROPLASTY 1 0.0001
526 INJECTION SITE RASH 2 0.0001
527 ANKLE FRACTURE 1 0.0001
528 INJECTION SITE ERYTHEMA 8 0.0001
529 BASAL CELL CARCINOMA 1 0.0001
530 PRODUCT USE COMPLAINT 1 0.0001
531 DRUG INTERACTION 10 0.0001
532 PREMATURE DELIVERY 1 0.0001
533 OBESITY 1 0.0001
534 METABOLIC ACIDOSIS 2 0.0001
535 SENSORY DISTURBANCE 1 0.0001
536 MOVEMENT DISORDER 2 0.0001
537 NIGHT SWEATS 2 0.0001
538 MUSCLE TIGHTNESS 1 0.0001
539 DRY MOUTH 5 0.0001
540 SWELLING FACE 4 0.0001
541 BLOOD CREATININE INCREASED 4 0.0001
542 IMPAIRED HEALING 2 0.0001
543 SEIZURE 7 0.0001
544 HEART RATE INCREASED 6 0.0001
545 BLOOD UREA INCREASED 1 0.0001
546 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
547 DISEASE PROGRESSION 7 0.0001
548 HEMIPARESIS 1 0.0001
549 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
550 INFLAMMATION 3 0.0001
551 ORTHOSTATIC HYPOTENSION 1 0.0001
552 LOCAL SWELLING 1 0.0001
553 MUSCULOSKELETAL PAIN 3 0.0001
554 BURNING SENSATION 4 0.0001
555 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
556 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
557 ISCHAEMIC STROKE 1 0.0001
558 GALLBLADDER DISORDER 1 0.0001
559 OSTEOMYELITIS 1 0.0001
560 HYPERGLYCAEMIA 2 0.0001
561 BONE DISORDER 1 0.0001
562 LOSS OF CONSCIOUSNESS 7 0.0001
563 ANAPHYLACTIC REACTION 3 0.0001
564 SEPSIS 6 0.0001
565 BACTERIAL INFECTION 1 0.0001
566 CARDIAC DISORDER 5 0.0001
567 COLITIS 2 0.0001
568 BLOOD URINE PRESENT 1 0.0001
569 GASTRIC ULCER 1 0.0001
570 PROTEINURIA 1 0.0001
571 FEELING JITTERY 1 0.0001
572 SLEEP APNOEA SYNDROME 1 0.0001
573 CHOLESTASIS 1 0.0001
574 DRUG PRESCRIBING ERROR 1 0.0001
575 ACUTE RESPIRATORY FAILURE 1 0.0001
576 HERNIA 1 0.0001
577 ERUCTATION 1 0.0001
578 ATRIAL FIBRILLATION 5 0.0001
579 SINUS DISORDER 1 0.0001
580 DISORIENTATION 2 0.0001
581 SPINAL FRACTURE 1 0.0000
582 FEEDING DISORDER 1 0.0000
583 TASTE DISORDER 1 0.0000
584 VERTIGO 3 0.0000
585 BODY TEMPERATURE INCREASED 1 0.0000
586 INJECTION SITE PAIN 15 0.0000
587 PRODUCT PREPARATION ERROR 1 0.0000
588 ERYTHEMA 10 0.0000
589 RIB FRACTURE 1 0.0000
590 INJECTION SITE WARMTH 1 0.0000
591 ABDOMINAL PAIN UPPER 10 0.0000
592 PERITONITIS 1 0.0000
593 RHABDOMYOLYSIS 2 0.0000
594 MOUTH ULCERATION 1 0.0000
595 GAIT DISTURBANCE 9 0.0000
596 IRRITABLE BOWEL SYNDROME 1 0.0000
597 HYPERHIDROSIS 6 0.0000
598 HYPOACUSIS 2 0.0000
599 PRURITUS GENERALISED 1 0.0000
600 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
601 SEPTIC SHOCK 2 0.0000
602 BLOOD PRESSURE INCREASED 7 0.0000
603 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
604 MUSCULOSKELETAL STIFFNESS 4 0.0000
605 FEBRILE NEUTROPENIA 3 0.0000
606 BLOOD PRESSURE DECREASED 3 0.0000
607 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
608 TACHYCARDIA 4 0.0000
609 TOOTH DISORDER 1 0.0000
610 INJECTION SITE PRURITUS 3 0.0000
611 ORAL PAIN 1 0.0000
612 SNEEZING 1 0.0000
613 PARAESTHESIA 7 0.0000
614 PANCREATITIS ACUTE 1 0.0000
615 HEART RATE IRREGULAR 1 0.0000
616 MUSCULAR WEAKNESS 5 0.0000
617 SKIN IRRITATION 2 0.0000
618 MUSCLE SPASMS 8 0.0000
619 TINNITUS 2 0.0000
620 SKIN DISCOLOURATION 2 0.0000
621 SHOCK 1 0.0000
622 PERICARDIAL EFFUSION 1 0.0000
623 CHEST PAIN 8 0.0000
624 HYPERSENSITIVITY 8 0.0000
625 COGNITIVE DISORDER 2 0.0000
626 PALPITATIONS 5 0.0000
627 ARRHYTHMIA 2 0.0000
628 TREMOR 7 0.0000
629 DYSPHAGIA 4 0.0000
630 COMA 2 0.0000
631 RASH ERYTHEMATOUS 2 0.0000
632 MULTIPLE SCLEROSIS 2 0.0000
633 URTICARIA 7 0.0000
634 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
635 TOXICITY TO VARIOUS AGENTS 7 0.0000
636 INTERSTITIAL LUNG DISEASE 2 0.0000
637 INJECTION SITE URTICARIA 1 0.0000
638 PAIN 25 0.0000
639 BRONCHITIS 3 0.0000
640 PYREXIA 14 0.0000
641 NAUSEA 32 0.0000
642 DIZZINESS 20 0.0000
643 PNEUMONIA ASPIRATION 1 0.0000
644 CELLULITIS 2 0.0000
645 HAEMATEMESIS 1 0.0000
646 FLUSHING 4 0.0000
647 INJECTION SITE SWELLING 3 0.0000
648 HEPATITIS 1 0.0000
649 BACK PAIN 9 0.0000
650 RASH GENERALISED 1 0.0000
651 ABDOMINAL DISTENSION 4 0.0000
652 VOMITING 18 0.0000
653 NERVOUSNESS 2 0.0000
654 MUCOSAL INFLAMMATION 1 0.0000
655 SEDATION 1 0.0000
656 SPEECH DISORDER 2 0.0000
657 ARTHRITIS 3 0.0000
658 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
659 PAIN OF SKIN 1 0.0000
660 CONFUSIONAL STATE 6 0.0000
661 DISTURBANCE IN ATTENTION 2 0.0000
662 THROAT TIGHTNESS 1 0.0000
663 RASH PRURITIC 2 0.0000
664 OEDEMA 2 0.0000
665 HEADACHE 23 0.0000
666 MOOD ALTERED 1 0.0000
667 INFLUENZA LIKE ILLNESS 3 0.0000
668 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
669 RESPIRATORY DISTRESS 1 0.0000
670 DIVERTICULITIS 1 0.0000
671 PROCEDURAL PAIN 1 0.0000
672 MENTAL STATUS CHANGES 1 0.0000
673 FEELING COLD 1 0.0000
674 INFLUENZA 4 0.0000
675 PANCYTOPENIA 2 0.0000
676 NECK PAIN 2 0.0000
677 SKIN EXFOLIATION 3 0.0000
678 HYPERSOMNIA 1 0.0000
679 BALANCE DISORDER 3 0.0000
680 PANCREATIC CARCINOMA 1 0.0000
681 LIVER FUNCTION TEST ABNORMAL 1 0.0000
682 DYSSTASIA 1 0.0000
683 CHILLS 4 0.0000
684 ACUTE MYOCARDIAL INFARCTION 1 0.0000
685 LABORATORY TEST ABNORMAL 1 0.0000
686 WHEEZING 2 0.0000
687 HYPOAESTHESIA 5 0.0000
688 PREMATURE BABY 1 0.0000
689 HEPATIC FAILURE 1 0.0000
690 LACRIMATION INCREASED 1 0.0000
691 HYPERTENSION 7 0.0000
692 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
693 CORONARY ARTERY DISEASE 1 0.0000
694 PLEURAL EFFUSION 2 0.0000
695 DRUG ADMINISTRATION ERROR 1 0.0000
696 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
697 EXPOSURE DURING PREGNANCY 2 0.0000
698 CYSTITIS 1 0.0000
699 EYE DISORDER 1 0.0000
700 EXPIRED PRODUCT ADMINISTERED 1 0.0000
701 VIRAL INFECTION 1 0.0000
702 FUNGAL INFECTION 1 0.0000
703 SYNCOPE 3 0.0000
704 GAIT INABILITY 1 0.0000
705 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
706 FEELING ABNORMAL 7 0.0000
707 GASTRIC DISORDER 1 0.0000
708 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
709 INJECTION SITE REACTION 2 0.0000
710 DELIRIUM 1 0.0000
711 HEART RATE DECREASED 1 0.0000
712 SLEEP DISORDER 2 0.0000
713 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
714 OVERDOSE 6 0.0000
715 INFECTION 4 0.0000
716 PANIC ATTACK 1 0.0000
717 RESPIRATORY FAILURE 2 0.0000
718 DYSURIA 1 0.0000
719 FALL 9 0.0000
720 DYSGEUSIA 2 0.0000
721 THROMBOCYTOPENIA 3 0.0000
722 ASTHENIA 10 0.0000
723 DYSPNOEA EXERTIONAL 1 0.0000
724 ASTHMA 3 0.0000
725 UNEVALUABLE EVENT 2 0.0000
726 PERIPHERAL SWELLING 4 0.0000
727 PLASMA CELL MYELOMA 1 0.0000
728 SOMNOLENCE 5 0.0000
729 BLINDNESS 1 0.0000
730 LUNG NEOPLASM MALIGNANT 1 0.0000
731 DRUG INEFFECTIVE 32 0.0000
732 CARDIO-RESPIRATORY ARREST 1 0.0000
733 ROAD TRAFFIC ACCIDENT 1 0.0000
734 PAIN IN EXTREMITY 7 0.0000
735 URINARY TRACT INFECTION 4 0.0000
736 PRURITUS 9 0.0000
737 RECTAL HAEMORRHAGE 1 0.0000
738 DEVICE DISLOCATION 1 0.0000
739 MENTAL DISORDER 1 0.0000
740 CONSTIPATION 5 0.0000
741 ANGIOEDEMA 1 0.0000
742 RENAL FAILURE 3 0.0000
743 DRY SKIN 3 0.0000
744 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
745 VISION BLURRED 3 0.0000
746 HYPOKALAEMIA 1 0.0000
747 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
748 PNEUMONIA 7 0.0000
749 OROPHARYNGEAL PAIN 2 0.0000
750 WEIGHT DECREASED 6 0.0000
751 BLOOD CHOLESTEROL INCREASED 1 0.0000
752 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
753 COUGH 6 0.0000
754 OCULAR HYPERAEMIA 1 0.0000
755 PULMONARY EMBOLISM 2 0.0000
756 DISEASE RECURRENCE 1 0.0000
757 PRODUCTIVE COUGH 1 0.0000
758 CONTUSION 2 0.0000
759 HYPOGLYCAEMIA 1 0.0000
760 OFF LABEL USE 18 0.0000
761 ALOPECIA 4 0.0000
762 DYSPEPSIA 2 0.0000
763 DRY EYE 1 0.0000
764 LEUKOPENIA 1 0.0000
765 FATIGUE 15 0.0000
766 ECZEMA 1 0.0000
767 ARTHROPATHY 1 0.0000
768 BLISTER 1 0.0000
769 EYE PAIN 1 0.0000
770 CEREBROVASCULAR ACCIDENT 3 0.0000
771 DYSPNOEA 10 0.0000
772 FLATULENCE 1 0.0000
773 PRODUCT SUBSTITUTION ISSUE 1 0.0000
774 DECREASED APPETITE 4 0.0000
775 BONE PAIN 1 0.0000
776 SURGERY 1 0.0000
777 NASAL CONGESTION 1 0.0000
778 IRRITABILITY 1 0.0000
779 JOINT SWELLING 2 0.0000
780 STOMATITIS 1 0.0000
781 CONDITION AGGRAVATED 5 0.0000
782 OEDEMA PERIPHERAL 2 0.0000
783 FEELING HOT 1 0.0000
784 NASOPHARYNGITIS 3 0.0000
785 INFUSION RELATED REACTION 1 0.0000
786 NEUTROPENIA 2 0.0000
787 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
788 MEMORY IMPAIRMENT 2 0.0000
789 ARTHRALGIA 6 0.0000
790 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
791 ANXIETY 4 0.0000
792 THERAPY INTERRUPTED 1 0.0000
793 SKIN BURNING SENSATION 1 0.0000
794 DIARRHOEA 9 0.0000
795 RASH 6 0.0000
796 EPISTAXIS 1 0.0000
797 HALLUCINATION 1 0.0000
798 CHRONIC KIDNEY DISEASE 1 0.0000
799 INCORRECT DOSE ADMINISTERED 3 0.0000
800 ACUTE KIDNEY INJURY 2 0.0000
801 HOSPITALISATION 2 0.0000
802 ABDOMINAL PAIN 3 0.0000
803 CARDIAC FAILURE 1 0.0000
804 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
805 ABDOMINAL DISCOMFORT 2 0.0000
806 RENAL IMPAIRMENT 1 0.0000
807 MYOCARDIAL INFARCTION 2 0.0000
808 DRUG WITHDRAWAL SYNDROME 1 0.0000
809 INSOMNIA 3 0.0000
810 DEVICE ISSUE 1 0.0000
811 ADVERSE DRUG REACTION 1 0.0000
812 NO ADVERSE EVENT 2 0.0000
813 ADVERSE EVENT 1 0.0000
814 SWELLING 1 0.0000
815 PRODUCT USE ISSUE 2 0.0000
816 MIGRAINE 1 0.0000
817 DRUG INTOLERANCE 1 0.0000
818 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
819 CHEST DISCOMFORT 1 0.0000
820 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
821 HAEMOGLOBIN DECREASED 1 0.0000
822 ILLNESS 1 0.0000
823 HAEMORRHAGE 1 0.0000
824 PLATELET COUNT DECREASED 1 0.0000
825 DEATH 8 0.0000
826 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
827 MALAISE 4 0.0000
828 DEHYDRATION 1 0.0000
829 DRUG DOSE OMISSION 1 0.0000
830 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
831 BLOOD GLUCOSE INCREASED 1 0.0000
832 ANAEMIA 1 0.0000
833 WEIGHT INCREASED 1 0.0000
834 DEPRESSION 1 0.0000